Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Haloperidol vs. Risperidone in First-Episode Schizophrenia
NCT00159081Phase 4Completed
- Sponsor
- Heinrich Heine University Düsseldorf
- Start
- Nov 2000
- Primary completion
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of risperidone in schizophrenia, sponsored by Heinrich Heine University Düsseldorf. Started Nov 2000; status: completed.
02
Drugs
risperidone
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00159081.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00159081.